Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
APVOthis companyAptevo Therapeutics Inc.	$1.16	-0.11×	0×	0×	0.66×	379114.3%	0.0%	0.0%	0.0%	-149.4%	-119.5%	-86018.8%	0.27×	0.66×	0×	3.82×	0.0%	1	-33.17	2	B-
BCDABioCardia, Inc.	$0.90	-1.02×	9.31×	0×	-0.82×	-76.9%	0.0%	0.0%	0.0%	-919.3%	-581.7%	-89.3%	0.59×	0.25×	0×	1.12×	0.0%	1	-51.25	2	C
ERNAErnexa Therapeutics Inc.	$1.73	-0.54×	3.15×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-586.6%	-316.6%	-93.2%	0.2×	0.1×	-345.15×	1.01×	0.0%	2	-64.61	2	B-
HCWBHCW Biologics Inc.	$1.02	-0.09×	0.74×	37.52×	-1.22×	-4178.9%	20.0%	-20757.6%	-14677.1%	-287.9%	-109.7%	-658.1%	2.46×	-0.86×	-9×	0.11×	0.0%	2	-6.89	2	C
INABIN8bio, Inc.	$0.95	-0.53×	0.37×	0×	0.83×	503.4%	0.0%	0.0%	0.0%	-70.5%	-65.5%	-124.2%	0.1×	1.44×	0×	8.82×	0.0%	2	-10.08	3	B-
KPRXKiora Pharmaceuticals, Inc.	$1.50	-0.75×	0.5×	0×	0.02×	56.4%	0.0%	0.0%	0.0%	-67.2%	-40.7%	-124.6%	0.02×	0.69×	-473.91×	5.99×	0.0%	2	-9.47	3	B-
Peer median	—	-0.54×	0.74×	0×	-0.45×	-4.7%	0.0%	0.0%	0.0%	-287.9%	-109.7%	-124.2%	0.2×	0.25×	-9×	1.12×	0.0%	2	-10.08	2	—